Liu David Y
SEC CIK 1675881 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Chief R, D Strategy Off | 80.9K | — | $702.9K | 5 | 2021-08-17 | 2022-11-16 |
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Liu David Y made no open-market trades at PTGX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-17 | 2022-11-16 | PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief R, D Strategy Off | M - OptEx | $2.31 | +100.5K | 80.9K | New | +$231.8K |
| 2022-03-02 | 2022-02-28 | PTGX | Protagonist Therapeutics, Inc | Liu David Y | CSO | F - Tax | $24.28 | -2,119 | 66.5K | -3% | -$51.4K | |
| D | 2022-02-17 | 2022-02-15 | PTGX | Protagonist Therapeutics, Inc | Liu David Y | CSO | A - Grant | $0.00 | +10.0K | 68.7K | +17% | $0 |
| D | 2021-08-19 | 2021-08-17 | PTGX | Protagonist Therapeutics, Inc | Liu David Y | CSO | S - Sale+OE | $47.56 | -14.8K | 58.3K | -20% | -$702.9K |
| D | 2021-08-19 | 2021-08-17 | PTGX | Protagonist Therapeutics, Inc | Liu David Y | CSO | M - OptEx | $0.87 | +10.0K | 73.0K | +16% | +$8,700 |
Purchase Sale Sale after option exercise All abbreviations